Surpass’ innovative approach to preclinical research goes beyond the ordinary. We’re changing the rules for a better way to get from concept to reality.

Surpass is a leading preclinical contract research organization (CRO) in the heart of medical innovation, the Greater Twin Cities, with recognized expertise in surgical and interventional studies for medical devices, pharmaceuticals, biologics, and combination products. Our preclinical testing services in large in vivo models and human cadavers span the product development cycle (proof-of-concept, early feasibility, iterative prototype evaluations, surgical modeling, human factors assessments, validation, pharmacokinetics (PK), GLP/safety studies, and physician bio-skills training).

At Surpass, we bring more to our client partners. Our award-winning Research Team provides insightful solutions and assistance every step of the way, offering expert advice and the level of comprehensive support needed to make your study successful – the first time. For the medtech or biotech entrepreneur, Surpass has a series of support programs specifically designed for early-stage medical innovation. Whether you need assistance completing the preclinical components of a grant submission package, or help in selecting the appropriate model and refining your study design, our team stands ready to support you as active members of your team.

For an experienced translational research partner to advance your product to market, look to Surpass – a committed member of the medical innovation continuum. More information about Surpass’ can be found at www.surpassinc.com.